Kidney Cancer Coverage from Every Angle
Editor:
Robert J. Motzer, MD
Advertisement
Advertisement

Recent News

ASCO-SITC 2020: Is Immune Primer in Renal Cell Cancer Ready for Prime Time?
Enzyme Identified as Potential Target in von Hippel-Lindau–Deficient Kidney Cancer
METEOR Trial: Age-Based Outcomes With Cabozantinib for Renal Cell Carcinoma
Later-Line Therapy for Renal Cell Carcinoma: Tivozanib Versus Sorafenib
Development of Radiomic Signatures in Renal Cell Carcinoma
FDA Grants Regulatory Approval to Expand Use of Cryoablation to Treat Kidney Cancer
IKCS 2019: Evaluating CD73 Expression in Renal Cell Tumors
IKCS 2019: Challenges of Using ctDNA in Renal Cell Carcinoma
IKCS 2019: Novel ImmunoPET/CT Under Study in Renal Cell Carcinoma
IKCS 2019: Comparing Patient- and Clinician-Reported Performance Status
IKCS 2019: Identifying a New Role for SETD2 in Clear Cell Renal Cell Carcinoma
IKCS 2019: Lenvatinib Plus Pembrolizumab in Subset of Patients With Kidney Cancer
IKCS 2019: Treatment-Free Survival With Immunotherapy Versus Sunitinib in Kidney Cancer
IKCS 2019: Histopathologic Changes Associated With Immunotherapy for Kidney Cancer
Robotic Radiosurgery for Kidney Cancer in Patients With Impaired Renal Function
First-in-Class Pegilodecakin Under Study in Advanced Renal Tumors
Could Virtual Reality Models for Surgical Planning Improve Nephrectomy Outcomes?
ESMO 2019: Avelumab Plus Axitinib for Advanced Renal Cell Carcinoma
ESMO 2019: Enfortumab Vedotin Plus Pembrolizumab in Advanced Bladder Cancer
ESMO 2019: Tailored Approach to Immunotherapy for Advanced Kidney Cancer
Quality Care 2019: Does Comprehensive Genomic Profiling Improve Outcomes in Metastatic Kidney Cancer?
Are Medical Students and Residents Staying Away From Nephrology?
Tubular Progenitor Cells in End-Stage Kidney Disease and Papillary Adenomas
Quality Care 2019: Cost of Treatment Per Episode of Care in Metastatic Kidney Cancer
Studying NR1B2 as Tumor Suppressor in Renal Clear Cell Carcinoma
Urine Metabolic Profiles: Potential Key to Diagnosing Kidney Cancer
Microarray Technology Brings More Precise Diagnosis for Rare Kidney Cancer
Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.